Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 342

PubMed (Weighted) Links for Protein (Select 4505219)

1.

Relationship of serum MMP-7 levels for colorectal cancer: a meta-analysis.

Xing XJ, Gu XH, Ma TF.

Tumour Biol. 2014 Oct;35(10):10515-22. doi: 10.1007/s13277-014-2349-3. Epub 2014 Jul 25.

PMID:
25060179
2.

Pericellular proteolysis by matrix metalloproteinase-7 is differentially modulated by cholesterol sulfate, sulfatide, and cardiolipin.

Yamamoto K, Miyazaki K, Higashi S.

FEBS J. 2014 Aug;281(15):3346-56. doi: 10.1111/febs.12865. Epub 2014 Jul 7.

PMID:
24903600
3.

Matrix metalloproteinase 7 is a useful marker for 5-fluorouracil-based adjuvant chemotherapy in stage II and stage III colorectal cancer patients.

Huang Y, Yu H, Lei H, Xie C, Zhong Y.

Med Oncol. 2014 Mar;31(3):824. doi: 10.1007/s12032-013-0824-0. Epub 2014 Jan 28.

PMID:
24469951
4.

MMP7 expression in colorectal tumours of different stages.

Polistena A, Cucina A, Dinicola S, Stene C, Cavallaro G, Ciardi A, Orlando G, Arena R, D'Ermo G, Cavallaro A, Johnson LB, De Toma G.

In Vivo. 2014 Jan-Feb;28(1):105-10.

PMID:
24425843
5.

Matrix metalloproteinase 7 is associated with symptomatic lesions and adverse events in patients with carotid atherosclerosis.

Abbas A, Aukrust P, Russell D, Krohg-Sørensen K, Almås T, Bundgaard D, Bjerkeli V, Sagen EL, Michelsen AE, Dahl TB, Holm S, Ueland T, Skjelland M, Halvorsen B.

PLoS One. 2014 Jan 6;9(1):e84935. doi: 10.1371/journal.pone.0084935. eCollection 2014.

6.

Matrix metalloproteinase7 -181A/G polymorphism is associated with increased cancer risk among high-quality studies: Evidence from a meta-analysis.

Wu J, Guan X, Li YT, Bai P, Wu J.

Clin Biochem. 2013 Nov;46(16-17):1649-54. doi: 10.1016/j.clinbiochem.2013.07.015. Epub 2013 Jul 27.

PMID:
23895900
7.

Current evidence on associations between the MMP-7 (-181A>G) polymorphism and digestive system cancer risk.

Ke P, Wu ZD, Wen HS, Ying MX, Long HC, Qing LG.

Asian Pac J Cancer Prev. 2013;14(4):2269-72.

8.

Update meta-analysis on MMP-7 -181A>G polymorphism and cancer risk: evidence from 25 studies.

Yang X, Liu Y, Yang Y, Li B.

Gene. 2013 Jun 1;521(2):252-8. doi: 10.1016/j.gene.2013.03.079. Epub 2013 Apr 2.

PMID:
23562717
9.

[The expression level and clinical significance of MMP-7 protein in peripheral blood in the patients with lung cancer].

Sun X, Xiao T, Yang L, Gao Y, Cheng G, Sun K.

Zhongguo Fei Ai Za Zhi. 2012 Dec;15(12):725-9. doi: 10.3779/j.issn.1009-3419.2012.12.06. Chinese.

10.

Expression and prognostic value of matrix metalloproteinase-7 in colorectal cancer.

Yang B, Su K, Gao J, Rao Z.

Asian Pac J Cancer Prev. 2012;13(3):1049-52.

11.

Is MMP-7 gene polymorphism a possible risk factor for chronic obstructive pulmonary disease in Turkish patients.

Mogulkoc U, Coskunpinar E, Aynaci E, Cağlar E, Ortakoylu MG, Ozkan G, Oltulu YM, Eraltan IY.

Genet Test Mol Biomarkers. 2012 Jun;16(6):519-23. doi: 10.1089/gtmb.2011.0271. Epub 2012 Mar 14.

PMID:
22417142
12.

A possibility of a protein-bound water molecule as the ionizable group responsible for pKe at the alkaline side in human matrix metalloproteinase 7 activity.

Morishima A, Yasukawa K, Inouye K.

J Biochem. 2012 May;151(5):501-9. doi: 10.1093/jb/mvs016. Epub 2012 Feb 24.

PMID:
22368250
13.

A/G Polymorphism of the MMP-7 Gene Promoter Region in Colorectal Cancer.

Dziki L, Przybyłowska K, Majsterek I, Trzciński R, Mik M, Sygut A.

Pol Przegl Chir. 2011 Nov;83(11):622-6. doi: 10.2478/v10035-011-0098-1.

PMID:
22246095
14.

Matrilysin (MMP-7) inhibition of BMP-7 induced renal tubular branching morphogenesis suggests a role in the pathogenesis of human renal dysplasia.

McGuire JK, Harju-Baker S, Rims C, Sheen JH, Liapis H.

J Histochem Cytochem. 2012 Mar;60(3):243-53. doi: 10.1369/0022155411435152. Epub 2012 Jan 3.

15.

MMP7 -181G allele is a low-penetrant risk factor for cancer development in East Asians.

Yuan-Yuan M, Li-Feng Z, Li-Jie Z.

DNA Cell Biol. 2012 May;31(5):772-6. doi: 10.1089/dna.2011.1416. Epub 2011 Nov 2.

PMID:
22047080
16.

Down-regulation of matrix metalloproteinase-7 inhibits metastasis of human anaplastic thyroid cancer cell line.

Chen ST, Liu DW, Lin JD, Chen FW, Huang YY, Hsu BR.

Clin Exp Metastasis. 2012 Jan;29(1):71-82. doi: 10.1007/s10585-011-9430-8. Epub 2011 Nov 1.

PMID:
22042554
17.

Antisense oligonucleotide targeting matrix metalloproteinase-7 (MMP-7) changes the ultrastructure of human A549 lung adenocarcinoma cells.

Yang B, Gao J, Rao Z, Zhang B, Ouyang W, Yang C.

Ultrastruct Pathol. 2011 Dec;35(6):256-9. doi: 10.3109/01913123.2011.610564. Epub 2011 Oct 7.

PMID:
21981819
18.

Association of matrix metalloproteinase-7 (-181A>G) polymorphism with risk of esophageal squamous cell carcinoma in Kashmir Valley.

Malik MA, Sharma KL, Zargar SA, Mittal B.

Saudi J Gastroenterol. 2011 Sep-Oct;17(5):301-6. doi: 10.4103/1319-3767.84480.

19.

Thermodynamic analysis of ionizable groups involved in the catalytic mechanism of human matrix metalloproteinase 7 (MMP-7).

Takeharu H, Yasukawa K, Inouye K.

Biochim Biophys Acta. 2011 Dec;1814(12):1940-6. doi: 10.1016/j.bbapap.2011.07.008. Epub 2011 Jul 23.

PMID:
21787888
20.

Association of a functional polymorphism in the MMP7 gene promoter with susceptibility to vulnerable carotid plaque in a Han Chinese population.

Hu XF, Jin XP, Hu PY, Zhu M, Wang F, Lin XF, Li WL, Ni H, Yang LH.

Clin Chem Lab Med. 2011 Oct;49(10):1735-41. doi: 10.1515/CCLM.2011.241. Epub 2011 Jul 4.

PMID:
21722074
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk